Stay updated on CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.

Latest updates to the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded revision: v3.5.0 and removed revision: v3.4.3 from the record history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision entry v3.4.3 was added to the record history, and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded revision v3.4.2 and removed revision v3.4.1 from the study's record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry (v3.4.1) was added to the history, and outdated notices about funding and the older revision (v3.4.0) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check64 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center's operating status was added to the page.SummaryDifference0.8%

- Check71 days agoChange DetectedGlossary toggle and color-coded highlights were added, and the revision notice updated to v3.4.0; the No FEAR Act data line was removed.SummaryDifference1%

Stay in the know with updates to CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.